United States · FDA National Drug Code directory

THEOPHYLLINE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 69315-227_a7dacdee-6f6b-4b85-b051-7779258a6971
Product NDC: 69315-227
Form: TABLET, EXTENDED RELEASE
Composition / generic term: THEOPHYLLINE
Labeler: Leading Pharma, LLC
Marketing category: ANDA
Marketing start / end (source format): 20230515
Source listing expiry: 20261231

Source-listed ingredients

THEOPHYLLINE — 450 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69315-227-01) · 69315-227-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →